Childhood Cancers | Tumor

CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.

Oncology Drugs Approved by the FDA in October 2024

November 1st 2024, 7:00pm

Article

During October, the FDA approved drugs to treat diseases including breast cancer, lung cancer, leukemia and gastric cancer.

Yankees Gift World Series Tickets to Pediatric Patient, “The Warriors” Star Dies and More

November 1st 2024, 3:00pm

Article

From World Series tickets given to a pediatric patient with cancer to the death of David Harris, known as Cochise in “The Warriors,” at the age of 75, here is this week’s cancer news.

FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia

October 29th 2024, 3:00pm

Article

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.

My Daughter Talked Through Her Eyes During Cancer

September 21st 2024, 6:00pm

Article

When my daughter couldn't express her words while she received treatment for brain cancer, her eyes told me everything I needed to know.

Genetic Variations Influence Relapse Risk for Some Children with B-ALL

August 15th 2024, 9:00pm

Article

Researchers have identified genetic differences that can make leukemia relapse more or less likely among pediatric patients.

FDA Approves Niktimvo for Chronic GVHD

August 14th 2024, 7:36pm

Article

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.

Teddi Mellencamp Reveals More Melanoma Lesions, Michael Strahan’s Daughter Cancer-Free and More

July 19th 2024, 3:00pm

Article

From Teddi Mellencamp revealing that she had more melanoma spots removed to Isabella Strahan announcing being cancer-free, here’s what’s happening in the oncology space this week.

Augtyro Approved in NTRK-Positive Cancers, Pediatric Research Continues

July 4th 2024, 7:00am

Article

The Food and Drug Administration recently approved Augtyro for the treatment of patients ages 12 and older with solid tumors harboring an NTRK gene fusion.

FDA Approves Retevmo for Some Adults and Children With Thyroid Cancer

June 12th 2024, 7:00pm

Article

The Food and Drug Administration granted a traditional approval to Retevmo for adult and pediatric patients 2 years old and older with advanced or metastatic RET fusion-positive thyroid cancer.

FDA Approves Retevmo for RET-Positive Pediatric Cancers

May 29th 2024, 4:41pm

Article

Retevmo was approved for childhood metastatic medullary thyroid, thyroid and solid tumors with RET mutations or gene fusions.